FDA approves Incyte's eczema cream with boxed warnings
Go back to FDA approves Incyte's eczema cream with boxed warnings| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 127.99 -0.48 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.47 | 52 Week High | $118.49 | |||
| Open | $127.10 | 52 Week Low | $55.00 | |||
| Day High | $129.80 | P/E | N/A | |||
| Day Low | $127.01 | EPS | $-0.56 | |||
| Volume | 546,790 | |||||
